Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 1.5 AUD -0.99% Market Closed
Market Cap: 405.3m AUD

Intrinsic Value

The intrinsic value of one IMR stock under the Base Case scenario is 2.05 AUD. Compared to the current market price of 1.5 AUD, Imricor Medical Systems Inc is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMR Intrinsic Value
2.05 AUD
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Imricor Medical Systems Inc

Valuation History Unavailable

Historical valuation for IMR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare IMR to

Fundamental Analysis

Imricor Medical Systems Inc
ASX:IMR
US
Health Care
Market Cap
405.3m AUD
IPO
Aug 30, 2019
US
Health Care
Market Cap
405.3m AUD
IPO
Aug 30, 2019
Price
AU$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IMR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Imricor Medical Systems Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Imricor Medical Systems Inc

Current Assets 18.3m
Cash & Short-Term Investments 15.7m
Receivables 345.3k
Other Current Assets 2.3m
Non-Current Assets 3.3m
PP&E 2.6m
Other Non-Current Assets 677.4k
Efficiency

Free Cash Flow Analysis
Imricor Medical Systems Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Imricor Medical Systems Inc

Revenue
959.4k USD
Cost of Revenue
-1.9m USD
Gross Profit
-924.1k USD
Operating Expenses
-15.4m USD
Operating Income
-16.3m USD
Other Expenses
-13.4m USD
Net Income
-29.7m USD
Fundamental Scores

IMR Profitability Score
Profitability Due Diligence

Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional Revenue Growth Forecast
Exceptional ROE
ROE is Increasing
42/100
Profitability
Score

Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

IMR Solvency Score
Solvency Due Diligence

Imricor Medical Systems Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Positive Net Debt
Long-Term Solvency
41/100
Solvency
Score

Imricor Medical Systems Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMR Price Targets Summary
Imricor Medical Systems Inc

Wall Street analysts forecast IMR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMR is 2.33 AUD with a low forecast of 2.3 AUD and a high forecast of 2.39 AUD.

Lowest
Price Target
2.3 AUD
54% Upside
Average
Price Target
2.33 AUD
55% Upside
Highest
Price Target
2.39 AUD
60% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Imricor Medical Systems Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IMR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IMR Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IMR stock?

The intrinsic value of one IMR stock under the Base Case scenario is 2.05 AUD.

Is IMR stock undervalued or overvalued?

Compared to the current market price of 1.5 AUD, Imricor Medical Systems Inc is Undervalued by 27%.

Back to Top